查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1863143

全球眼科黏弹性器材市场：洞察、竞争格局及至2032年预测

Ophthalmic Viscoelastic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

眼科黏弹性器材市场摘要

  • 全球眼科黏弹性设备市场预计将从 2024 年的 4.593 亿美元成长到 2032 年的 6.8497 亿美元，反映出强劲且持续的成长。
  • 全球眼科黏弹性装置市场在预测期（2025 年至 2032 年）内将以 5.21% 的复合年增长率成长。
  • 眼科黏弹性设备市场的主要驱动因素包括眼科疾病盛行率上升、产品设计技术进步、眼部保健意识和可及性提高、糖尿病盛行率上升以及主要市场参与者产品开发活动增加。
  • 眼科黏弹性器材市场的主要企业包括：B. Braun SE、BestMedical、MINZE HEALTH、Santron Medtronic、Potent Medical、Laborie、MEDKONSULT medical technology sro、The Prometheus Group®、HCItalia srl、DeltaMed、MEDICA SPA、AymedIA SEVS. Ltd、Stericom Ltd、Amecath Medical Technologies、Cook 和 Well Lead Medical Co.。
  • 由于白内障和青光眼的高发病率、人口快速老化以及先进眼科手术的日益普及，北美预计将主导整个眼科黏弹性器械市场。该地区拥有完善的医疗基础设施、技术精湛的眼科医生以及优惠的医保报销政策。此外，市场领导者的存在和持续的产品创新也进一步巩固了北美在全球市场的主导地位。
  • 在眼科黏弹性器械市场按类型分類的细分市场中，预计到 2024 年，黏性眼科黏弹性器械类别将占据最大的市场份额。

眼科黏弹性器材市场成长要素

  • 眼科疾病发生率上升导致眼科黏弹性製剂需求激增：白内障、青光眼和糖尿病视网膜病变等眼科疾病的日益普遍，推动了眼科黏弹性製剂需求的激增，因为这些产品在确保眼科手术的安全性和精确性方面发挥着关键作用。随着全球病例数量的增加，尤其是在人口老化的情况下，为了满足不断增长的眼科手术需求，对黏弹性製剂的需求也显着增加。
  • 眼科保健意识的提高和医疗服务的普及正在推动眼科黏弹性製剂市场的发展：人们对眼部健康的日益关注以及眼科保健服务的普及，尤其是在发展中地区，正在扩大眼科黏弹性製剂的市场。政府措施、宣传宣传活动以及越来越多的眼科专科医院和手术中心，使得更多患者能够接受先进的眼科手术，从而促进了黏弹性製剂的应用。
  • 产品设计的技术进步：随着新一代眼科黏弹性製剂（OVD）的推出，产品设计的技术进步正在推动眼科黏弹性製剂市场的发展。新一代OVD具有更高的黏度、稳定性和安全性。诸如聚集分散配方和增强的生物相容性等创新正在改善手术效果，提高外科医生的偏好，并促进其在眼科手术中的广泛应用。

眼科黏弹性器材市场报告细分

本研究报告全面概​​述了全球眼科黏弹性器材市场，重点阐述了关键趋势、成长驱动因素、挑战和机会。该报告按类型、应用、最终用户和地区对市场进行了详细细分，并深入分析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态。报告还详细介绍了行业领导企业的概况和近期产品开发情况，为企业识别市场潜力、制定战略规划以及把握快速增长的眼科黏弹剂市场中的新机会提供了重要数据。

眼科黏弹性物质（OVD），也称为眼科黏弹剂，是一种用于眼科手术的透明凝胶状物质。 「黏弹性」一词源自于其双重特性：既具有液体的黏性，又具有固体或凝胶的弹性。这些物质是现代眼科手术，特别是白内障和人工水晶体（IOL）植入术中不可或缺的工具。这些器械对前房施加压力，将眼内组织分隔成不同的区域，有助于稳定脆弱的眼部结构，从而加快患者的术后恢復，使手术更加轻鬆安全。

眼科黏弹性製剂市场整体成长主要受眼科疾病盛行率上升和手术需求增加的推动，同时，不断提升製剂性能和安全性的技术进步也起到了重要作用。人们对眼科保健的认识不断提高，眼科医疗服务的可及性也随之扩大了患者群体，而糖尿病患病率的上升进一步加重了需要手术治疗的视力相关疾病的负担。此外，主要厂商加大产品研发力度，推出创新黏弹性製剂解决方案，进一步促进了全球市场成长。

眼科黏弹性物质（OVD）市场正经历显着成长，主要驱动因素是白内障、青光眼、糖尿病视网膜病变和屈光不正等眼科疾病的日益普遍。根据DelveInsight的一项分析（2024年）显示，全球有超过22.5亿人因近视和远视而患有视力障碍，这推动了对矫正眼科手术的需求。不断扩大的全球患者群体正在推动OVD的应用，因为OVD在稳定前房、保护角膜内皮和提高手术精度方面发挥着至关重要的作用。

白内障手术仍然是黏弹剂的主要应用领域。光是在英国，2023年就将进行超过51.6万例白内障手术（英国政府，2024年5月），凸显了老龄化社会中手术数量的不断增长。由于白内障手术是全球最常见的眼科手术，预计对黏弹剂的需求也将随之增长，尤其是在医疗基础设施完善、报销机制健全的已开发市场。

糖尿病视网膜病变（DR）是糖尿病最常见的眼部併发症之一，也是导致糖尿病的重要因素，因为它通常需要手术干预，例如玻璃体切除术合併白内障手术。根据DelveInsight估计（2024年），全球将有超过1亿成年人患有DR，其中近2,900万例为威胁视力的DR（VTDR）。这些手术严重依赖黏弹剂（OVD）来维持前房深度并确保组织处理安全，而黏弹剂的应用正在扩大。

除了疾病负担之外，眼科手术技术的进步也推动了对黏弹剂的需求。飞秒雷射辅助白内障手术、微创青光眼手术（MIGS）以及高端人工水晶体（IOL）的普及，都要求使用高品质的黏弹剂以确保手术的精准性和安全性。此外，兼具分散性和凝聚性的黏弹剂的日益普及，正在改善手术效果并拓宽其临床应用范围。

此外，人口结构变化，例如全球人口快速老化、糖尿病盛行率上升以及新兴市场先进眼科医疗服务可及性的提高，预计将进一步推动市场扩张。同时，旨在减少可避免失明和增加眼科医疗基础设施投资的政府利好政策也为市场发展注入了动力。

预计患者人数增加、手术数量增加、糖尿病相关併发症增加以及技术的不断进步将推动眼科黏弹性设备市场在预测期内显着增长。

然而，眼科黏弹性物质（OVD）市场面临许多挑战，主要原因是其高成本和复杂的报销机制，这会阻碍OVD的普及，尤其是在预算紧张的医疗体系中。此外，严格的监管障碍和漫长的核准流程也限制新型OVD的研发，减缓了创新步伐。医疗专业人员对OVD的认知不足和缺乏专业培训也限制了其有效应用，构成了一项重大的营运挑战。而且，如果OVD使用或移除不当，始终存在术后併发症的风险，例如眼压升高。该市场也面临众多厂商的激烈竞争，以及替代手术技术可能减少对OVD的需求。这些因素，加上原材料价格的波动，共同构成了OVD市场面临的重大限制和复杂性。

眼科黏弹性器材市场細項分析

眼科黏弹性器材市场按类型、应用、最终用户和地区划分

眼科黏弹性器材市场区域分析

北美眼科黏弹性器材市场趋势

预计北美将在2024年主导全球眼科黏弹性物质（OVD）市场，约占全球市场份额的41%。这一主导主要得益于白内障和青光眼的高发病率，以及人口快速老化，从而推动了眼科手术数量的增长。该地区先进的医疗基础设施、强大的眼科医生网络以及完善的医保报销体系，进一步促进了高端手术技术的应用，巩固了其在全球市场的地位。

根据DelveInsight 2024年的分析，光是在美国，就有超过2,550万人将患上白内障，约970万人将患上糖尿病视网膜病变（DR），这是导致糖尿病相关视力障碍的主要原因。虽然白内障和视网膜病变通常需要进行手术治疗，例如白内障摘除术和玻璃体切除术，但黏弹剂（OVD）对于维持前房稳定、保护角膜内皮以及确保人工水晶体（IOL）的精准植入至关重要。随着糖尿病和老龄化相关眼科疾病的持续增加，预计北美地区的手术患者数量将显着增长，从而推动对黏弹剂的持续需求。

技术创新也是推动该地区成长的因素之一。新一代黏弹剂具有优化的黏度特性、双重作用（聚集和分散）以及预填充输送系统，从而提高了手术效率、安全性和精准度。例如，爱尔康的DUOVISC®黏弹性系统结合了PROVISC®（聚集）和VISCOAT®（分散）两种技术，可在白内障手术中为外科医生提供机械支撑和内皮保护。同样，博士伦的StableVisc™和TotalVisc™系统也反映了双重作用黏弹剂的发展趋势，能够改善组织保护和手术效果。这些创新不仅减少了併发症和手术时间，还拓展了黏弹剂的应用范围，使其能够应用于包括青光眼治疗和糖尿病眼部併发症在内的更多手术。

此外，北美OVD市场受益于Alcon、博士伦和强生视力等全球领导企业的存在，以及FDA频繁的核准和产品上市。该地区在飞秒雷射辅助白内障手术、微创青光眼手术（MIGS）和高端人工水晶体植入等先进眼科技术的早期应用方面也处于领先地位，所有这些技术都高度依赖黏弹性物质来实现最佳效果。

预计在预测期内，庞大且不断增长的患者群体、不断增加的手术量、强大的医疗保健基础设施、有利的报销政策以及持续的产品创新将共同推动北美 OVD 市场实现显着且持续的增长，从而巩固其作为全球领导者的地位。

欧洲黏弹性眼科器材市场趋势

欧洲正引领眼科黏弹性物质（OVD）市场的成长，这主要得益于多种因素的共同作用，包括眼科疾病的高发生率、完善的医疗基础设施以及先进外科手术的普及。该地区人口老化，加上白内障和视力障碍疾病盛行率的上升，推动了手术中对OVD的需求。此外，欧洲各国在眼科研发领域蓬勃发展，推动了安全性和有效性不断提高的创新黏弹性产品的问世。政府的各项措施、优惠的医疗政策以及日益增强的眼部健康意识，进一步促进了OVD在医院和专业眼科中心的应用。市场领导者的存在以及OVD配方技术的持续进步，也巩固了欧洲作为全球眼科黏弹性物质市场主要贡献者的地位。

亚太地区眼科黏弹性器材市场趋势

亚太地区正崛起为眼科黏弹性物质（OVD）市场的重要成长要素，这主要得益于视力障碍患者的快速成长、医疗基础设施的不断完善以及先进眼科手术的日益普及。在中国、印度和日本等国家，人口老化和糖尿病发生率的上升导致白内障、青光眼和糖尿病视网膜病变的盛行率不断攀升。眼科专科医疗服务的普及、政府促进眼部健康的倡议以及医院和手术中心的扩建，都推动了OVD的应用。此外，患者和医疗专业人员对黏弹性物质益处的认识不断提高，也促进了其在都市区和半都市区的应用。庞大的未满足医疗需求、不断增长的手术量以及不断扩大的医疗投资，共同推动了亚太地区成为全球OVD市场成长的重要贡献者。

以下列出了眼科黏弹性器械市场的主要企业，它们总合占据最大的市场份额，并引领着行业趋势：

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology sro
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA SPA
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.
  • 其他的

眼科黏弹性物质（OVD）市场竞争异常激烈，少数几家大型跨国公司，尤其是爱尔康、强生视力保健、博士伦和卡尔蔡司医疗，占据了大部分市场份额。这种高度的市场集中度源于研发、监管核准以及建立产品安全性和有效性良好声誉所需的大量投资。这些市场领导利用其丰富的产品组合，提供各种类型的OVD（包括凝聚型、分散型和黏弹性OVD），并经常将其与其他手术器械捆绑销售，以赢得医院和诊所的订单。然而，儘管这些跨国公司占据主导地位，市场中也存在一些规模较小、更专业的公司，区域性企业，尤其是在亚太地区，正在不断崛起。这种充满活力的市场环境鼓励持续创新，透过专注于开发能够改善手术效果、便于取出并满足特定手术需求的下一代OVD，推动市场发展，迫使竞争对手透过技术和品质来脱颖而出。

眼科黏弹性器材市场最新发展

  • 2025年2月，FDA核准了VIA360™手术系统。 VIA360旨在眼科手术（包括小梁切开术）期间输送可控剂量的黏弹性液体。
  • 2023 年 4 月，博士伦在美国推出了 StableVisc™ 和 TotalVisc™ 黏弹性眼科手术器械，为外科医生提供先进的双重作用保护，并在白内障手术中提高安全性。

眼科黏弹性器材市场细分

  • 暴露的眼科黏弹性装置类型
  • 黏性眼科黏弹性物质
  • 分散型眼科黏弹性物质
  • 复合眼科黏弹性物质
  • 黏弹性眼科黏弹性
  • 眼科黏弹性装置应用范围
  • 白内障手术
  • 青光眼手术
  • 角膜移植
  • 玻璃体视网膜手术
  • 其他的
  • 眼科黏弹性器材的终端用户市场
  • 医院
  • 眼科诊所
  • 其他的
  • 黏弹性眼科器械的区域发展趋势
  • 北美眼科黏弹性器材市场
  • 美国眼科黏弹性器材市场
  • 加拿大眼科黏弹性器材市场
  • 墨西哥眼科黏弹性器材市场
  • 欧洲眼科黏弹性器材市场
  • 英国眼科黏弹性器材市场
  • 德国眼科黏弹性器材市场
  • 法国眼科黏弹性器材市场
  • 义大利眼科黏弹性器材市场
  • 西班牙眼科黏弹性器材市场
  • 其他欧洲眼科黏弹性器材市场
  • 亚太地区眼科黏弹性器材市场
  • 中国眼科黏弹性器材市场
  • 日本眼科黏弹性器材市场
  • 印度眼科黏弹性器材市场
  • 澳洲眼科黏弹性器材市场
  • 韩国眼科黏弹性器材市场
  • 亚太地区其他眼科黏弹性器材市场
  • 世界其他地区眼科黏弹性器材市场
  • 南美洲眼科黏弹性器材市场
  • 中东眼科黏弹性器材市场
  • 非洲眼科黏弹性器材市场

影响分析

人工智慧驱动的创新正日益影响眼科黏弹性物质（OVD）市场，提升手术精准度、安全性和病患疗效。先进的人工智慧演算法与眼科成像系统相结合，能够分析每位患者的眼部解剖结构和状况，从而为特定手术推荐最合适的OVD类型，例如内聚型、分散型、混合型或黏弹性适应型。在人工智慧辅助或机器人辅助的白内障和前节手术中，人工智慧可以优化OVD注射速度、剂量和注射位置等参数，以确保前房稳定并降低併发症风险。此外，人工智慧驱动的预测模型能够帮助外科医生预测术后结果，并指导个人化OVD选择和手术策略。在产品开发方面，人工智慧和机器学习正被用于模拟黏弹性特性和组织相互作用，加速设计具有更高生物相容性、黏度和双重作用能力的下一代OVD。总而言之，这些人工智慧驱动的创新不仅提高了手术效率和病人安全，而且还扩大了眼科黏弹性装置在现代眼科护理中的应用和发展。

美国关税对眼科黏弹性器材市场的影响分析

美国关税政策对眼科黏弹性物质（OVD）市场构成重大挑战，对製造商和医疗服务提供者都有影响。 2025年，美国对大多数进口医疗设备和组件征收5%的基本关税，其中包括OVD生产所必需的关键原材料，例如透明质酸钠。

如此高的关税会导致更高的製造成本，而这些成本往往会转嫁给医疗服务提供者和患者，这可能会影响眼科手术的可负担性和可及性。眼镜产业对这类贸易政策表示担忧，强调视力保健产品的重要性及其对企业（尤其是小型企业和独立零售商）带来的经济负担。

为应对这些挑战，企业正在寻求替代筹资策略，例如供应链多元化和扩大国内生产，以减轻关税的影响。然而，持续进行的贸易谈判以及未来潜在的关税调整所带来的不确定性，仍然对美国眼科手术（OVD）市场的稳定和成长构成风险。

目录

第一章 眼科黏弹性器材市场报告概述

  • 调查范围
  • 市场区隔
  • 市场假设

2. 眼科黏弹性器材市场执行摘要

  • 市场概览

第三章：眼科黏弹性器材市场关键因素分析

  • 市场驱动因素
    • 眼科疾病率不断上升
    • 提高大众对眼科护理的认识和获取途径
    • 科技进步日新月异
    • 主要市场参与企业的产品开发活动增加
  • 市场限制与挑战
    • 与OVD移除相关的风险
    • 高成本和报销难题
    • 监管障碍和严格的核准流程
  • 市场机会
    • 新型OVD配方具有改进的性能，包括更高的黏度。

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

6. 眼科黏弹性器材市场：波特五力分析

第七章 眼科黏弹性器材市场评估

  • 按类型
    • 黏性眼科黏弹剂
    • 可分散眼科黏弹剂
    • 复合眼科黏弹性剂
    • 黏弹性眼科材料
  • 透过使用
    • 白内障手术
    • 青光眼手术
    • 角膜移植
    • 玻璃体视网膜手术
    • 其他的
  • 最终用户
    • 医院
    • 眼科诊所
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

10. 眼科黏弹性器材市场中的公司和产品概况

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron
  • Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology sro
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA SPA
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0134

Ophthalmic Viscoelastic Devices Market Summary

  • The global ophthalmic viscoelastic devices market is expected to increase from USD 459.30 million in 2024 to USD 684.97 million by 2032, reflecting strong and sustained growth.
  • The global ophthalmic viscoelastic devices market is growing at a CAGR of 5.21% during the forecast period from 2025 to 2032.
  • The market of ophthalmic viscoelastic devices is being primarily driven by the rising prevalence of eye disorders, technological advancements in the product designs, rising awareness and access to eye care, an increase in diabetes prevalence, and an increase in product development activities among the key market players.
  • The leading companies operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.
  • North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.
  • In the type segment of the ophthalmic viscoelastic devices market, the cohesive ophthalmic viscoelastic category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ophthalmic Viscoelastic Devices Market

  • Rising prevalence of eye disorders leading to a surge in ophthalmic viscoelastic devices: The rising prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy is driving a surge in demand for ophthalmic viscoelastic devices, as these products play a critical role in ensuring safety and precision during eye surgeries. With increasing cases worldwide, especially among the aging population, the need for OVDs is growing significantly to support the rising volume of ophthalmic procedures.
  • Rising awareness and access to eye care are escalating the market of ophthalmic viscoelastic devices: Rising awareness about eye health and expanding access to ophthalmic care, particularly in developing regions, are escalating the market for ophthalmic viscoelastic devices. Government initiatives, awareness campaigns, and improved availability of specialized eye hospitals and surgical centers are driving higher adoption of OVDs by enabling more patients to undergo advanced eye surgeries.
  • Technological advancement in product design: Technological advancements in product design are boosting the ophthalmic viscoelastic devices market by introducing next-generation OVDs with improved viscosity, stability, and safety profiles. Innovations such as combination cohesive-dispersive formulations and enhanced biocompatibility are enabling better surgical outcomes, increasing surgeon preference, and driving wider adoption in ophthalmic procedures.

Ophthalmic Viscoelastic Devices Market Report Segmentation

This ophthalmic viscoelastic devices market report offers a comprehensive overview of the global Ophthalmic Viscoelastic Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ophthalmic viscoelastic devices market.

Ophthalmic viscoelastic devices (OVDs), also known as ophthalmic viscosurgical devices, are a class of clear, gel-like substances used in eye surgery. The name "viscoelastic" comes from their dual properties: the viscosity of a fluid and the elasticity of a solid or gel. These substances are essential tools in modern eye surgery, particularly in cataract and intraocular lens (IOL) implantation procedures. These devices help secure the fragile eye structures, along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.

The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

What are the latest Ophthalmic Viscoelastic Devices Market Dynamics and Trends?

The ophthalmic viscoelastic devices (OVDs) market is witnessing significant growth, primarily driven by the increasing prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and refractive errors. According to DelveInsight's analysis (2024), over 2.25 billion people worldwide suffer from near or distance vision impairment, creating a robust demand for corrective eye surgeries. Since OVDs play a vital role in stabilizing the anterior chamber, protecting the corneal endothelium, and enhancing surgical precision, the expanding global patient pool directly supports higher adoption of these devices.

Cataract surgery remains the leading application area for OVDs. In England alone, more than 516,000 cataract surgeries were performed in 2023 (UK Government, May 2024), highlighting the increasing surgical volume in aging populations. With cataract surgery being the most frequently performed ophthalmic procedure globally, the demand for OVDs is set to grow in tandem, particularly in developed markets with advanced healthcare infrastructure and supportive reimbursement frameworks.

Diabetic retinopathy (DR) is another major contributor, as it is among the most common diabetes-related eye complications, often requiring surgical interventions such as vitrectomy or combined cataract procedures. DelveInsight's estimates (2024) indicate that more than 100 million adults worldwide were living with DR, with nearly 29 million cases of vision-threatening DR (VTDR). These surgical interventions heavily depend on OVDs to maintain anterior chamber depth and ensure safe tissue handling, further expanding their utilization.

Beyond disease burden, technological advancements in ophthalmic surgery are accelerating OVD demand. The adoption of femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium intraocular lenses (IOLs) necessitates the use of high-quality viscoelastics for precision and safety. Moreover, the increasing availability of combination OVDs (dispersive + cohesive properties) is enhancing surgical outcomes and broadening their clinical applications.

Additionally, demographic shifts such as the rapidly aging global population, rising diabetes prevalence, and improved access to advanced ophthalmic care in emerging markets are expected to further fuel market expansion. Favorable government initiatives aimed at reducing avoidable blindness and growing investments in eye-care infrastructure also add to the momentum.

Taken together, the convergence of a growing patient pool, rising surgical volumes, increasing diabetes-related complications, and ongoing technological advancements is expected to significantly propel the ophthalmic viscoelastic devices market over the forecast period.

However, the ophthalmic viscoelastic devices (OVDs) market faces significant challenges, primarily driven by the high cost and complex reimbursement landscape, which can hinder adoption, particularly in budget-constrained healthcare systems. The development of new OVDs is also constrained by stringent regulatory hurdles and lengthy approval processes, which slow down innovation. A key operational challenge is the lack of awareness and specialized training among healthcare professionals, limiting the effective use of these devices. Furthermore, there is a constant risk of post-operative complications, such as increased intraocular pressure, if the OVDs are not used or removed correctly. The market also contends with intense competition from numerous players, as well as the potential for displacement by alternative surgical techniques that may reduce the need for OVDs. These factors, alongside raw material price volatility, collectively create notable restraints and complexities for the OVD market.

Ophthalmic Viscoelastic Devices Market Segment Analysis

Ophthalmic Viscoelastic Devices Market by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ophthalmic Viscoelastic Devices Market Regional Analysis

North America Ophthalmic Viscoelastic Devices Market Trends

North America is projected to dominate the global ophthalmic viscoelastic devices (OVD) market in 2024, capturing nearly 41% of the total share. This leadership is underpinned by the high prevalence of cataracts and glaucoma, coupled with a rapidly aging population that fuels the rising number of ophthalmic surgical procedures. The region's advanced healthcare infrastructure, strong network of skilled ophthalmic surgeons, and supportive reimbursement frameworks further promote the adoption of premium surgical technologies, cementing its stronghold in the global market.

According to DelveInsight's analysis (2024), in the United States alone, over 25.5 million people were affected by cataracts, while approximately 9.7 million were living with diabetic retinopathy (DR), a leading diabetes-related cause of vision impairment. Both cataracts and DR frequently require surgical interventions such as cataract extraction and vitrectomy, in which OVDs are indispensable for maintaining anterior chamber stability, protecting the corneal endothelium, and ensuring accurate intraocular lens (IOL) implantation. With the continued rise in diabetes prevalence and age-related ocular disorders, the surgical patient pool in North America is set to expand significantly, driving sustained demand for OVDs.

Technological innovation is another key growth accelerator in the region. Next-generation OVDs feature optimized viscosity profiles, dual-action (cohesive-dispersive) properties, and prefilled delivery systems that improve surgical efficiency, safety, and precision. For example, Alcon's DUOVISC(R) Viscoelastic System, which combines PROVISC(R) (cohesive) with VISCOAT(R) (dispersive), provides surgeons with both mechanical support and endothelial protection during cataract procedures. Similarly, Bausch + Lomb's StableVisc(TM) and TotalVisc(TM) systems reflect the ongoing trend toward dual-action OVDs that enhance tissue protection and surgical outcomes. Such innovations not only reduce complications and procedure time but also expand OVD applications to a broader range of surgeries, including glaucoma management and diabetic eye complications.

Additionally, North America's OVD market is strengthened by the presence of leading global players such as Alcon, Bausch + Lomb, and Johnson & Johnson Vision, alongside frequent FDA approvals and product launches that accelerate adoption. The region also leads in the early integration of advanced ophthalmic technologies, including femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium IOL implantation, all of which rely heavily on viscoelastic devices for optimal outcomes.

Taken together, the combination of a large and expanding patient pool, rising surgical volumes, robust healthcare infrastructure, favorable reimbursement, and ongoing product innovation is expected to fuel substantial and sustained growth of the North American OVD market over the forecast period, reinforcing its position as the global leader.

Europe Ophthalmic Viscoelastic Devices Market Trends

Europe is driving the growth of the ophthalmic viscoelastic devices (OVD) market through a combination of factors, including a high prevalence of eye disorders, well-established healthcare infrastructure, and increasing access to advanced surgical procedures. The region has a significant aging population, which contributes to a rising incidence of cataracts and other vision-impairing conditions, thereby increasing the demand for OVDs in surgeries. Additionally, European countries have strong ophthalmic research and development activities, fostering the introduction of innovative viscoelastic products with improved safety and efficacy. Government initiatives, favorable reimbursement policies, and growing awareness about eye health further support the adoption of OVDs across hospitals and specialized eye care centers. The presence of leading market players and continuous technological advancements in OVD formulations also reinforce Europe's position as a key contributor to the overall growth of the global ophthalmic viscoelastic devices market.

Asia-Pacific Ophthalmic Viscoelastic Devices Market Trends

The Asia-Pacific region is emerging as a major growth driver of the ophthalmic viscoelastic devices (OVD) market due to a rapidly increasing patient pool with vision disorders, expanding healthcare infrastructure, and rising adoption of advanced ophthalmic surgeries. Countries such as China, India, and Japan are witnessing a growing prevalence of cataracts, glaucoma, and diabetic retinopathy, driven by aging populations and increasing rates of diabetes. Improved access to specialized eye care, government initiatives promoting eye health, and the expansion of hospitals and surgical centers are facilitating higher OVD utilization. Additionally, growing awareness among patients and healthcare professionals about the benefits of viscoelastic devices is boosting adoption in both urban and semi-urban regions. The combination of high unmet medical needs, increasing surgical volumes, and expanding healthcare investments makes the Asia-Pacific region a significant contributor to the global OVD market growth.

Who are the major players in the ophthalmic viscoelastic devices market?

The following are the leading companies in the ophthalmic viscoelastic devices market. These companies collectively hold the largest market share and dictate industry trends.

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology s.r.o.
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA S.P.A
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.
  • Others

How is the competitive landscape shaping the ophthalmic viscoelastic devices market?

The competitive landscape of the ophthalmic viscoelastic devices (OVD) market is highly consolidated, with a few major global players, notably Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec, holding a significant portion of the market share. This high market concentration is driven by the considerable investment required for research and development, regulatory approval, and building a strong reputation for product safety and efficacy. These market leaders leverage their extensive portfolios to offer a full range of OVD types (cohesive, dispersive, and viscoadaptive), often bundling them with other surgical equipment to secure contracts with hospitals and clinics. However, despite the dominance of these multinational corporations, the market also features several smaller, specialized companies and a growing presence of regional players, especially in the Asia-Pacific region. This dynamic environment encourages continuous innovation, with companies focusing on developing next-generation OVDs that improve surgical outcomes, are easier to remove, and address specific surgical needs, thereby shaping the market's evolution and forcing competitors to differentiate through technology and quality.

Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market

  • In February 2025, the FDA granted clearance for the VIA360(TM) surgical system, designed to deliver controlled doses of viscoelastic fluid during ophthalmic surgeries, including trabeculotomy procedures.
  • In April 2023, Bausch + Lomb launched StableVisc(TM), a cohesive ophthalmic viscosurgical device, and the TotalVisc(TM) Viscoelastic System in the U.S., offering surgeons advanced dual-action protection and enhanced safety during cataract surgery.

Ophthalmic Viscoelastic Devices Market Segmentation

  • Ophthalmic Viscoelastic Devices Type Exposure
  • Cohesive Ophthalmic Viscoelastic
  • Dispersive Ophthalmic Viscoelastic
  • Combination Ophthalmic Viscoelastic
  • Visco-Adaptive Ophthalmic Viscoelastic
  • Ophthalmic Viscoelastic Devices Application Exposure
  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Transplantation
  • Vitreoretinal Surgery
  • Others
  • Ophthalmic Viscoelastic Devices End-Users Exposure
  • Hospitals
  • Ophthalmology Clinics
  • Others
  • Ophthalmic Viscoelastic Devices Geography Exposure
  • North America Ophthalmic Viscoelastic Devices Market
  • United States Ophthalmic Viscoelastic Devices Market
  • Canada Ophthalmic Viscoelastic Devices Market
  • Mexico Ophthalmic Viscoelastic Devices Market
  • Europe Ophthalmic Viscoelastic Devices Market
  • United Kingdom Ophthalmic Viscoelastic Devices Market
  • Germany Ophthalmic Viscoelastic Devices Market
  • France Ophthalmic Viscoelastic Devices Market
  • Italy Ophthalmic Viscoelastic Devices Market
  • Spain Ophthalmic Viscoelastic Devices Market
  • Rest of Europe Ophthalmic Viscoelastic Devices Market
  • Asia-Pacific Ophthalmic Viscoelastic Devices Market
  • China Ophthalmic Viscoelastic Devices Market
  • Japan Ophthalmic Viscoelastic Devices Market
  • India Ophthalmic Viscoelastic Devices Market
  • Australia Ophthalmic Viscoelastic Devices Market
  • South Korea Ophthalmic Viscoelastic Devices Market
  • Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market
  • Rest of the World Ophthalmic Viscoelastic Devices Market
  • South America Ophthalmic Viscoelastic Devices Market
  • Middle East Ophthalmic Viscoelastic Devices Market
  • Africa Ophthalmic Viscoelastic Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are increasingly influencing the ophthalmic viscoelastic devices (OVD) market by enhancing surgical precision, safety, and patient outcomes. Advanced AI algorithms integrated with ophthalmic imaging and diagnostic systems can analyze individual patient anatomy and ocular conditions to recommend the most appropriate type of OVD, whether cohesive, dispersive, combination, or visco-adaptive, for specific procedures. In AI-assisted or robotic-assisted cataract and anterior segment surgeries, AI can optimize parameters such as injection rate, volume, and placement of the OVD, ensuring stable anterior chamber maintenance and reducing the risk of complications. Additionally, AI-driven predictive models help surgeons anticipate post-operative outcomes, guiding the selection of OVDs and surgical strategies tailored to each patient. On the product development side, AI and machine learning are used to simulate viscoelastic properties and tissue interactions, accelerating the design of next-generation OVDs with improved biocompatibility, viscosity, and dual-action performance. Collectively, these AI-powered innovations are not only improving surgical efficiency and patient safety but also expanding the adoption and evolution of ophthalmic viscoelastic devices in modern ophthalmology.

U.S. Tariff Impact Analysis on Ophthalmic Viscoelastic Devices Market:

The U.S. tariff landscape has introduced significant challenges to the ophthalmic viscoelastic devices (OVD) market, impacting both manufacturers and healthcare providers. In 2025, the U.S. imposed a universal 5% baseline tariff on most imported medical devices and components, including critical raw materials like sodium hyaluronate, essential for OVD production.

These elevated tariffs have led to increased production costs, which are often passed on to healthcare providers and patients, potentially affecting the affordability and accessibility of eye surgeries. The optical industry has expressed concerns over these trade policies, highlighting the essential nature of vision care products and the financial strain on businesses, particularly smaller enterprises and independent retailers.

In response to these challenges, companies are exploring alternative sourcing strategies, such as diversifying supply chains and increasing domestic production, to mitigate the impact of tariffs. However, the uncertainty surrounding ongoing trade negotiations and potential future tariff adjustments continues to pose risks to the stability and growth of the OVD market in the U.S.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the ophthalmic viscoelastic devices market report study

  • Market size analysis for the current ophthalmic viscoelastic devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the ophthalmic viscoelastic devices market.
  • Various opportunities available for the other competitors in the ophthalmic viscoelastic devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current ophthalmic viscoelastic devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the ophthalmic viscoelastic devices market growth in the future?

Frequently Asked Questions for the Ophthalmic Viscoelastic Devices Market

1. What is the growth rate of the ophthalmic viscoelastic devices market?

  • The ophthalmic viscoelastic devices market is estimated to grow at a CAGR of 5.21% during the forecast period from 2025 to 2032.

2. What is the market for ophthalmic viscoelastic devices?

  • The ophthalmic viscoelastic devices market was valued at USD 459.30 million in 2024, and is expected to reach USD 684.97 million by 2032.

3. Which region has the highest share in the ophthalmic viscoelastic devices market?

  • North America is expected to dominate the overall ophthalmic viscoelastic devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.

4. What are the drivers for the ophthalmic viscoelastic devices market?

  • The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

5. Who are the key players operating in the ophthalmic viscoelastic devices market?

  • Some of the key market players operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron, Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.

Table of Contents

1. Ophthalmic Viscoelastic Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Ophthalmic Viscoelastic Devices Market Executive Summary

  • 2.1 Market at Glance

3. Ophthalmic Viscoelastic Devices Market Key Factors Analysis

  • 3.1 Ophthalmic Viscoelastic Devices Market Drivers
    • 3.1.1 Rising prevalence of eye disorders
    • 3.1.2 Rising awareness and access to eye care
    • 3.1.3 Increase in technological advancement
    • 3.1.4 Increase in product development activities among the key market players
  • 3.2 Ophthalmic Viscoelastic Devices Market Restraints and Challenges
    • 3.2.1 Risk associated with OVD removal
    • 3.2.2 High Cost and Reimbursement Challenges
    • 3.2.3 Regulatory Hurdles and Stringent Approval Processes
  • 3.3 Ophthalmic Viscoelastic Devices Market Opportunity
    • 3.3.1 Formulations of new OVDs with improved properties, such as enhanced viscosity

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Ophthalmic Viscoelastic Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Ophthalmic Viscoelastic Devices Market Assessment

  • 7.1 By Type
    • 7.1.1 Cohesive Ophthalmic Viscoelastic
    • 7.1.2 Dispersive Ophthalmic Viscoelastic
    • 7.1.3 Combination Ophthalmic Viscoelastic
    • 7.1.4 Visco-Adaptive Ophthalmic Viscoelastic
  • 7.2 By Application
    • 7.2.1 Cataract Surgery
    • 7.2.2 Glaucoma Surgery
    • 7.2.3 Corneal Transplantation
    • 7.2.4 Vitreoretinal Surgery
    • 7.2.5 Others
  • 7.3 By End-Users
    • 7.3.1 Hospitals
    • 7.3.2 Ophthalmology Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.1.2 Canada Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.1.3 Mexico Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2 Europe
      • 7.4.2.1 France Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.2 Germany Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.3 United Kingdom Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.4 Italy Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.5 Spain Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.6 Rest of Europe Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.2 Japan Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.3 India Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.4 Australia Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.5 South Korea Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.6 Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.4.2 Africa Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.4.3 South America Ophthalmic Viscoelastic Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ophthalmic Viscoelastic Devices Market Company and Product Profiles

  • 10.1 B. Braun SE
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 BestMedical
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 MINZE HEALTH
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Santron
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Medtronic
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Potent Medical
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Laborie
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 MEDKONSULT medical technology s.r.o.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 The Prometheus Group(R)
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 HCItalia srl
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 DeltaMed
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 MEDICA S.P.A
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Aymed Medical Technology
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 EV.SERVICE ITALIA
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 tic Medizintechnik GmbH & Co. KG
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Creo Medical Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Stericom Ltd.
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Amecath Medical Technologies
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Cook
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Well Lead Medical Co., Ltd.
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Ophthalmic Viscoelastic Devices Market in Global (2022-2032)
  • Table 2: Ophthalmic Viscoelastic Devices Market in Global by Type (2022-2032)
  • Table 3: Ophthalmic Viscoelastic Devices Market in Global by End-User (2022-2032)
  • Table 4: Ophthalmic Viscoelastic Devices Market in Global by Geography (2022-2032)
  • Table 5: Ophthalmic Viscoelastic Devices Market in North America (2022-2032)
  • Table 6: Ophthalmic Viscoelastic Devices Market in the United States (2022-2032)
  • Table 7: Ophthalmic Viscoelastic Devices Market in Canada (2022-2032)
  • Table 8: Ophthalmic Viscoelastic Devices Market in Mexico (2022-2032)
  • Table 9: Ophthalmic Viscoelastic Devices Market in Europe (2022-2032)
  • Table 10: Ophthalmic Viscoelastic Devices Market in France (2022-2032)
  • Table 11: Ophthalmic Viscoelastic Devices Market in Germany (2022-2032)
  • Table 12: Ophthalmic Viscoelastic Devices Market in United Kingdom (2022-2032)
  • Table 13: Ophthalmic Viscoelastic Devices Market in Italy (2022-2032)
  • Table 14: Ophthalmic Viscoelastic Devices Market in Spain (2022-2032)
  • Table 15: Ophthalmic Viscoelastic Devices Market in the Rest of Europe (2022-2032)
  • Table 16: Ophthalmic Viscoelastic Devices Market in Asia-Pacific (2022-2032)
  • Table 17: Ophthalmic Viscoelastic Devices Market in China (2022-2032)
  • Table 18: Ophthalmic Viscoelastic Devices Market in Japan (2022-2032)
  • Table 19: Ophthalmic Viscoelastic Devices Market in India (2022-2032)
  • Table 20: Ophthalmic Viscoelastic Devices Market in Australia (2022-2032)
  • Table 21: Ophthalmic Viscoelastic Devices Market in South Korea (2022-2032)
  • Table 22: Ophthalmic Viscoelastic Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 23: Ophthalmic Viscoelastic Devices Market in the Rest of the World (2022-2032)
  • Table 24: Ophthalmic Viscoelastic Devices Market in the Middle East (2022-2032)
  • Table 25: Ophthalmic Viscoelastic Devices Market in Africa (2022-2032)
  • Table 26: Ophthalmic Viscoelastic Devices Market in South America (2022-2032)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Ophthalmic Viscoelastic Devices Market Drivers
  • Figure 2: Ophthalmic Viscoelastic Devices Market Restraints
  • Figure 3: Ophthalmic Viscoelastic Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Ophthalmic Viscoelastic Devices Market
  • Figure 5: US Tariff Impact on Ophthalmic Viscoelastic Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Ophthalmic Viscoelastic Devices Market in Global (2022-2032)
  • Figure 10: Ophthalmic Viscoelastic Devices Market in Global by Type (2022-2032)
  • Figure 11: Ophthalmic Viscoelastic Devices Market in Global by End-User (2022-2032)
  • Figure 12: Ophthalmic Viscoelastic Devices Market in Global by Geography (2022-2032)
  • Figure 13: Ophthalmic Viscoelastic Devices Market in North America (2022-2032)
  • Figure 14: Ophthalmic Viscoelastic Devices Market in the United States (2022-2032)
  • Figure 15: Ophthalmic Viscoelastic Devices Market in Canada (2022-2032)
  • Figure 16: Ophthalmic Viscoelastic Devices Market in Mexico (2022-2032)
  • Figure 17: Ophthalmic Viscoelastic Devices Market in Europe (2022-2032)
  • Figure 18: Ophthalmic Viscoelastic Devices Market in France (2022-2032)
  • Figure 19: Ophthalmic Viscoelastic Devices Market in Germany (2022-2032)
  • Figure 20: Ophthalmic Viscoelastic Devices Market in United Kingdom (2022-2032)
  • Figure 21: Ophthalmic Viscoelastic Devices Market in Italy (2022-2032)
  • Figure 22: Ophthalmic Viscoelastic Devices Market in Spain (2022-2032)
  • Figure 23: Ophthalmic Viscoelastic Devices Market in the Rest of Europe (2022-2032)
  • Figure 24: Ophthalmic Viscoelastic Devices Market in Asia-Pacific (2022-2032)
  • Figure 25: Ophthalmic Viscoelastic Devices Market in China (2022-2032)
  • Figure 26: Ophthalmic Viscoelastic Devices Market in Japan (2022-2032)
  • Figure 27: Ophthalmic Viscoelastic Devices Market in India (2022-2032)
  • Figure 28: Ophthalmic Viscoelastic Devices Market in Australia (2022-2032)
  • Figure 29: Ophthalmic Viscoelastic Devices Market in South Korea (2022-2032)
  • Figure 30: Ophthalmic Viscoelastic Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 31: Ophthalmic Viscoelastic Devices Market in the Rest of the World (2022-2032)
  • Figure 32: Ophthalmic Viscoelastic Devices Market in the Middle East (2022-2032)
  • Figure 33: Ophthalmic Viscoelastic Devices Market in Africa (2022-2032)
  • Figure 34: Ophthalmic Viscoelastic Devices Market in South America (2022-2032)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding & Investment Trends